Pricing

Immunomic Therapeutics

1 follower

‌

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.

Industries

Biotechnology

Headquarters

Rockville, United States

Employees

11-50

Links

Org chart

Teri Heiland

Chief Scientific Officer

Frances Harrison

SVP, Regulatory Affairs

Cara Sholter

VP, Quality Assurance

YONG KI KIM

Director of Finance

Board & advisors

Director

Director

Director

Chief Executive Officer

John H. Sampson

Scientific Advisory Board

E. Antonio Chiocca

Scientific Advisory Board

Mark Pardoll

Scientific Advisory Board

Scientific Advisor

Scientific Advisor

Director

Director

Teams

Scientific Team

9 people · 0 jobs

Directors

7 people · 0 jobs

Leadership Team

2 people · 0 jobs

Offices

HQ
6 positions, 0 job posts
WS
BB
+2

Similar companies

Tango Therapeutics

3 followers

Cellares

4 followers

Gilead Sciences

159 followers

Regeneron

129 followers

Illumina

78 followers

Agilent Technologies

80 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

GRAIL

28 followers

Cytiva

16 followers

PerkinElmer

12 followers

Explore companies